Flavoxate Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01148 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 2 | irritable bowel syndrome | KG + DL |
| 3 | specific developmental disorder | KG + DL |
| 4 | attention deficit-hyperactivity disorder | KG + DL |
| 5 | cauda equina syndrome | KG + DL |
| 6 | obsolete neurogenic bladder (disease) | KG + DL |
| 7 | gastroduodenitis | KG + DL |
| 8 | peptic ulcer disease | KG + DL |
| 9 | pharyngitis | KG + DL |
| 10 | chondromyxoid fibroma | KG + DL |
| 11 | faciodigitogenital syndrome | KG + DL |
| 12 | neurocirculatory asthenia | KG + DL |
| 13 | nasal cavity disease | KG + DL |
| 14 | acute laryngopharyngitis | KG + DL |
| 15 | common cold | KG + DL |
| 16 | gastroenteritis | KG + DL |
| 17 | autonomic nervous system disease | KG + DL |
| 18 | bronchitis | KG + DL |
| 19 | rhinitis | KG + DL |
| 20 | allergic urticaria | KG + DL |
| 21 | dysautonomia | KG + DL |
| 22 | overactive bladder (disease) | KG + DL |
| 23 | insomnia (disease) | KG + DL |
| 24 | papillary conjunctivitis | KG + DL |
| 25 | obsolete rare pulmonary disease | KG + DL |
| 26 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 27 | cold urticaria | KG + DL |
| 28 | nasopharyngitis | KG + DL |
| 29 | large intestine disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.